Thematics Asset Management Sells 16,000 Shares of Agilent Technologies, Inc. $A

Key Points

• Thematics Asset Management reduced its holdings in Agilent Technologies by 15.1%, selling 16,000 shares, which leaves them with a total of 89,657 shares valued at approximately $10.5 million at the end of the latest quarter.
• Agilent Technologies reported a 6% increase in revenue year-over-year, with quarterly earnings per share of $1.31, surpassing the consensus estimate of $1.26.
• Analyst price targets for Agilent Technologies have varied, with raises and cuts, ranging from a high of $160.00 to a low of $125.00, resulting in a consensus rating of "Moderate Buy".

Thematics Asset Management decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 15.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 89,657 shares of the medical research company's stock after selling 16,000 shares during the period. Thematics Asset Management's holdings in Agilent Technologies were worth $10,488,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in A. Whipplewood Advisors LLC raised its holdings in shares of Agilent Technologies by 286.2% in the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after acquiring an additional 186 shares during the last quarter. Sunbelt Securities Inc. increased its holdings in Agilent Technologies by 640.0% during the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock worth $30,000 after purchasing an additional 192 shares in the last quarter. Stone House Investment Management LLC bought a new stake in Agilent Technologies during the 1st quarter worth approximately $30,000. Opal Wealth Advisors LLC purchased a new stake in shares of Agilent Technologies in the first quarter worth approximately $31,000. Finally, Wood Tarver Financial Group LLC bought a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $34,000.

Wall Street Analyst Weigh In

A has been the topic of several analyst reports. UBS Group cut their target price on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research report on Thursday, May 29th. JPMorgan Chase & Co. cut their price objective on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a report on Thursday, May 29th. Wells Fargo & Company raised their price objective on shares of Agilent Technologies from $135.00 to $140.00 and gave the stock an "overweight" rating in a report on Thursday. Robert W. Baird boosted their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an "outperform" rating in a report on Thursday. Finally, TD Cowen increased their target price on Agilent Technologies to $150.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Agilent Technologies has an average rating of "Moderate Buy" and a consensus target price of $139.25.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the sale, the chief executive officer directly owned 37,448 shares of the company's stock, valued at $4,397,893.12. This trade represents a 3.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Agilent Technologies Price Performance

Shares of A stock traded up $6.48 on Thursday, reaching $125.17. The company's stock had a trading volume of 3,886,217 shares, compared to its average volume of 1,953,393. The company has a market capitalization of $35.56 billion, a P/E ratio of 30.91, a PEG ratio of 3.59 and a beta of 1.22. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The stock's 50 day simple moving average is $117.99 and its 200-day simple moving average is $116.89. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55.

Agilent Technologies (NYSE:A - Get Free Report) last posted its earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%.The business had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.67 billion. During the same period in the previous year, the business earned $1.32 earnings per share. The firm's revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, equities analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.